Global Heparin Market Growth 2019-2024

Published On: Mar 2019

Format: PDF

Publisher: LP infomation

Pages: 167

Report ID: 236639

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.

Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.

Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Heparin market will register a 3.3% CAGR in terms of revenue, the global market size will reach US$ 1200 million by 2024, from US$ 990 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Heparin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Heparin market by product type, application, key manufacturers and key regions and countries.

This study considers the Heparin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Heparin Sodium
Heparin Calcium
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
United States
Southeast Asia
Middle East & Africa
South Africa
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Changshan Pharm
Qianhong Bio-pharma
Aspen Oss
King-friend Biochemical Pharmaceutical
Dongcheng Biochemicals
Jiulong Biochemicals
Yino Pharma Limited

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Heparin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Heparin market by identifying its various subsegments.
Focuses on the key global Heparin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Heparin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Heparin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Heparin Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heparin Consumption 2014-2024
2.1.2 Heparin Consumption CAGR by Region
2.2 Heparin Segment by Type
2.2.1 Heparin Sodium
2.2.2 Heparin Calcium
2.2.3 Other
2.3 Heparin Consumption by Type
2.3.1 Global Heparin Consumption Market Share by Type (2014-2019)
2.3.2 Global Heparin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Heparin Sale Price by Type (2014-2019)
2.4 Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Heparin Consumption by Application
2.5.1 Global Heparin Consumption Market Share by Application (2014-2019)
2.5.2 Global Heparin Value and Market Share by Application (2014-2019)
2.5.3 Global Heparin Sale Price by Application (2014-2019)

3 Global Heparin by Players
3.1 Global Heparin Sales Market Share by Players
3.1.1 Global Heparin Sales by Players (2017-2019)
3.1.2 Global Heparin Sales Market Share by Players (2017-2019)
3.2 Global Heparin Revenue Market Share by Players
3.2.1 Global Heparin Revenue by Players (2017-2019)
3.2.2 Global Heparin Revenue Market Share by Players (2017-2019)
3.3 Global Heparin Sale Price by Players
3.4 Global Heparin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Heparin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Heparin by Regions
4.1 Heparin by Regions
4.1.1 Global Heparin Consumption by Regions
4.1.2 Global Heparin Value by Regions
4.2 Americas Heparin Consumption Growth
4.3 APAC Heparin Consumption Growth
4.4 Europe Heparin Consumption Growth
4.5 Middle East & Africa Heparin Consumption Growth

5 Americas
5.1 Americas Heparin Consumption by Countries
5.1.1 Americas Heparin Consumption by Countries (2014-2019)
5.1.2 Americas Heparin Value by Countries (2014-2019)
5.2 Americas Heparin Consumption by Type
5.3 Americas Heparin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6.1 APAC Heparin Consumption by Countries
6.1.1 APAC Heparin Consumption by Countries (2014-2019)
6.1.2 APAC Heparin Value by Countries (2014-2019)
6.2 APAC Heparin Consumption by Type
6.3 APAC Heparin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Heparin by Countries
7.1.1 Europe Heparin Consumption by Countries (2014-2019)
7.1.2 Europe Heparin Value by Countries (2014-2019)
7.2 Europe Heparin Consumption by Type
7.3 Europe Heparin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Heparin by Countries
8.1.1 Middle East & Africa Heparin Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Heparin Value by Countries (2014-2019)
8.2 Middle East & Africa Heparin Consumption by Type
8.3 Middle East & Africa Heparin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Heparin Distributors
10.3 Heparin Customer

11 Global Heparin Market Forecast
11.1 Global Heparin Consumption Forecast (2019-2024)
11.2 Global Heparin Forecast by Regions
11.2.1 Global Heparin Forecast by Regions (2019-2024)
11.2.2 Global Heparin Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Heparin Forecast by Type
11.8 Global Heparin Forecast by Application

12 Key Players Analysis
12.1 Hepalink
12.1.1 Company Details
12.1.2 Heparin Product Offered
12.1.3 Hepalink Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Hepalink News
12.2 Changshan Pharm
12.2.1 Company Details
12.2.2 Heparin Product Offered
12.2.3 Changshan Pharm Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Changshan Pharm News
12.3 Qianhong Bio-pharma
12.3.1 Company Details
12.3.2 Heparin Product Offered
12.3.3 Qianhong Bio-pharma Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Qianhong Bio-pharma News
12.4 Opocrin
12.4.1 Company Details
12.4.2 Heparin Product Offered
12.4.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Opocrin News
12.5 Pfizer
12.5.1 Company Details
12.5.2 Heparin Product Offered
12.5.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Pfizer News
12.6 Aspen Oss
12.6.1 Company Details
12.6.2 Heparin Product Offered
12.6.3 Aspen Oss Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Aspen Oss News
12.7 King-friend Biochemical Pharmaceutical
12.7.1 Company Details
12.7.2 Heparin Product Offered
12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 King-friend Biochemical Pharmaceutical News
12.8 Bioibérica
12.8.1 Company Details
12.8.2 Heparin Product Offered
12.8.3 Bioibérica Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Bioibérica News
12.9 Dongcheng Biochemicals
12.9.1 Company Details
12.9.2 Heparin Product Offered
12.9.3 Dongcheng Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Dongcheng Biochemicals News
12.10 Jiulong Biochemicals
12.10.1 Company Details
12.10.2 Heparin Product Offered
12.10.3 Jiulong Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Jiulong Biochemicals News
12.11 Tiandong
12.12 Xinbai
12.13 Yino Pharma Limited
12.14 Deebio

13 Research Findings and Conclusion